MedTrace Logo

3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension

NCT06205992 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-02-09

No results posted yet for this study

Summary

How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis. We plan to compare the ability of three demensional-magnetic resonance elastography (3D-MRE) to two demensional-magnetic resonance elastography (2D-MRE) to establish a risk stratification system and perform tailored management for portal hypertension in cirrhosis.

Conditions

  • Cirrhosis
  • Liver Portal Hypertension

Interventions

DEVICE

3D-MRE

All imaging studies were performed by using a 3.0-T MRI system (Signa HDx, GE Healthcare) with an eight-channel phasedarray body coil.

DEVICE

HVPG

HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures

DEVICE

2D-MRE

All imaging studies were performed by using a 3.0-T MRI system (Signa HDx, GE Healthcare) with an eight-channel phasedarray body coil.

DEVICE

HVPG

HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures

Sponsors & Collaborators

  • Shengjing Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-16
Primary Completion
2026-08-01
Completion
2026-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06205992 on ClinicalTrials.gov